Full name
NOVEL-ID SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
NOVEL-ID SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. M. BOBRZYŃSKIEGO 14, 30-348 KRAKÓW
TAX ID6762452927
Rate company:
NOVEL-ID SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID6762452927
KRS0000410370
Share capital93,350.00 zł
address
UL. M. BOBRZYŃSKIEGO 14, 30-348 KRAKÓW
Website
[email protected]Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
6762452927
REGON
122509806
KRS
0000410370
Legal form
limited liability company
Register Address
UL. M. BOBRZYŃSKIEGO 14, 30-348 KRAKÓW
Date of registration in KRS
2012-02-07
Date of commencement of economic activity
2012-02-07
Act signature
RDF/680897/24/904
Website
Pkd codes
72.11 - Research and experimental development on biotechnology
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
32.50.Z - Manufacture of medical and dental instruments and supplies
33.20 - Installation of industrial machinery and equipment and outfit
71.12.Z - Engineering activities and related technical consultancy
71.20 - Technical testing and analysis
72.19 - Other research and experimental development on natural sciences and engineering
74.10.Z - Specialised design activities
74.30 - Translation and interpretation activities
74.90 - Other professional, scientific and technical activities not elsewhere classified
Payer VAT status
Active
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2019 | 2021 | 2022 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | -5,3 | -5,2 | -2,3 | 56,6 |
EBITDA | -0,6 | -0,5 | -0,9 | -92,3 |
Short time liabilities | 3 | 4,8 | 3,6 | -24,4 |
Equity capital | 8,5 | -0,7 | -2,9 | -343,2 |
Operating profit (EBIT) | -5,3 | -5,2 | -2,1 | 59,6 |
Assets | 11,5 | 4,1 | 0,7 | -83,5 |
Net profit (loss) | -5,3 | -5,2 | -2,3 | 56,6 |
Cash | 0 | 1,3 | 0 | -96,9 |
Liabilities and provisions for liabilities | 3 | 4,8 | 3,6 | -24,4 |
Net income from sale | 5,4 | 7,7 | 7,4 | -3,3 |
Working assets | 0,8 | 2,9 | 0,7 | -76,8 |
Depreciation | 4,8 | 4,8 | 1,2 | -75 |
% | % | % | p.p. | |
Profitability of capital | -62,5 | 790,2 | 77,4 | -712,8 |
Equity capital to total assets | 73,7 | -16,1 | -432,9 | -416,8 |
Gross profit margin | -98,3 | -68,4 | -30,7 | 37,7 |
EBITDA Margin | -10,3 | -6,3 | -12,5 | -6,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 205 | 228 | 178 | -50 |
Current financial liquidity indicator | 0.27556803822517395 | 0.6126120686531067 | 0.18764692544937134 | -0,4 |
Net dept to EBITDA | 0.07439085841178894 | 2.7514522075653076 | -0.0753055140376091 | -2,9 |
Financial statements
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Catalina Valdivia Alvarez
Kraków
4CAE Krzysztof Matusiak
Warszawa
Molecular Biotech Mateusz Gielata
Warszawa
INVIGEN SPÓŁKA AKCYJNA
WARSZAWA